Increased nocturnal blood pressure may be a harbinger of microalbuminuria in patients with type 1 diabetes.

If obesity is the leading cause of type II diabetes, then why do thiazolidinediones (TZDs), the only available drugs that treats this form of diabetes, actually cause more weight gain?

Findings from two studies by the US Centers for Disease Control and Prevention indicate that the prevalence of overweight and obesity in the US continues to increase.

A 170% increase, from 84 to 228 million, in the developing countries

Patients with type 2 diabetes who are given fluoroquinolones in commonly prescribed doses apparently have a reduced risk of developing coronary heart disease.

Babies that are longer and weigh more at birth may have a lower risk of developing type 2 diabetes.

Further evidence to suggest that almonds could benefit our health hit the press this week as scientists in Canada report that almonds significantly lowered bad cholesterol levels in a study of people with high cholesterol.

Research has shown cardiovascular disease is a major cause of death in patients with type 1 diabetes.

Initially thought that MSI-1436 could be an effective treatment for HIV because it stopped the reproduction of the virus in the lab. But found it had a greater potential for an obesity treatment.

Formal patient education programs often fail because of low levels of motivation and compliance from the patient or reluctance from the physicians to respond to information provided by patients.